Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB

Acta Histochemica

Volumn 107, Issue 1, 2005, Pages 77-86

  Cejkova J ^a   Cejka C ^a   Zvarova J ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Amiloride; Cornea; u PA activity; UVB rays

Indexed keywords

ACTIVATION ANALYSIS; BIOCHEMISTRY; ENZYME INHIBITION; PATHOLOGY; SUBSTRATES; ULTRAVIOLET RADIATION;

CORNEAL HEALING; HISTOCHEMICAL STUDIES; KERATOCYTES; UROKINASE;

ENZYMES;

AMILORIDE; COUMARIN DERIVATIVE; PLACEBO; UROKINASE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA EPITHELIUM; CORNEA STROMA; CORNEA VASCULARIZATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HEALING; HISTOCHEMISTRY; INFLAMMATORY CELL; LACRIMAL FLUID; NONHUMAN; RABBIT; ULTRAVIOLET B RADIATION;

ORYCTOLAGUS CUNICULUS;

EID: 18044363712     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acthis.2004.11.005     Document Type: Article

References (41)

1. R.L. Avery, T.B. Connor, and M. Farazdaghi Systemic amiloride inhibits experimentally induced neovascularization Arch Ophthalmol 108 1990 1474 1476
2. S. Barlati, E. Marchina, C.A. Quaranta, F. Vigasio, and F. Semeraro Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair Exp Eye Res 51 1990 1 9
3. A. Berta, J. Tozser, and F.J. Holly Determination of plasminogen activator activities in normal and pathological human tears. The significance of tear plasminogen activators in the inflammatory and traumatic lesions of the cornea and the conjunctiva Acta Ophthalmol 68 1990 508 514
4. F. Blasi, J.D. Vassali, and K. Dano Urokinase-type plasminogen activator proenzyme, receptor, and inhibitors J Cell Biol 104 1987 801 804
5. M.D. Boyle, V.A. Chiodo, M.J. Lawman, A.P. Gee, and M. Young Urokinase a chemotactic factor for polymorphonuclear leukocytes in vivo J Immunol 139 1987 169 174
6. D. Cao, I.F. Mizukami, B.A. Garni-Wagner, A.L. Kindzelskii, R.F. Todd, L.A. Boxer, and H.R. Petty Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium J Immunol 154 1995 1817 1829
7. R. Carubelli, E. Robert, and R.E. Nordquist Role of active oxygen species in corneal ulceration Cornea 9 1990 161 169
8. J. Čejková, and Z. Lojda The damaging effect of UV rays below 320 nm on the rabbit anterior eye segment. II. Enzyme histochemical changes and plasmin activity after prolonged irradiation Acta Histochem 97 1995 183 188
9. J. Čejková, and Z. Lojda The appearance of active plasminogen activator of urokinase type (u-PA) in the rabbit anterior eye segment irradiated by UVB rays. A histochemical and biochemical study Acta Histochem 97 1995 257 262
10. J. Čejková, J. Zvárová, T. Andonova, and T. Ardan Comparative histochemical and biochemical studies on acid β-galactosidase activity in the experimentally injured rabbit cornea and tear fluid using the sensitive substrate β-galactoside-4- trifluoromethylumbelliferyl (HFC) Histol Histopathol 14 1999 471 478
11. J. Čejková, J. Zvárová, and Č. Čejka Dipeptidyl peptidase IV (DPPIV) activity in the tear fluid as an indicator of the severity of corneal injury a histochemical and biochemical study Histol Histopathol 3 2004 669 676
12. J. Čejková, S. Štípek, J. Crkovská, T. Ardan, J. Pláteník, Č. Čejka, and A. Midelfart UV rays, the prooxidant/antioxidant imbalance and oxidative eye damage Physiol Res 53 2004 1 10
13. D. Collen Tissue-type plasminogen activator a historical perspective and personal account J Thromb Haemost 2 2004 541 546
14. A. Csutak, J. Tozser, L. Bekesi, Z. Hassan, A. Berta, and D.M. Silver Plasminogen activator activity in tears after excimer laser photorefractive keratectomy Invest Ophthalmol Vis Sci 41 2000 3743 3747
15. N. Gilboa, P. Neumann, J.M. Gutmann, P.J. Vecchio, and P. Gudewicz Evidence for regulation of endothelial plasminogen-activating system by polymorphonuclear leukocyte elastase Thromb Res 54 1989 467 475
16. P.W. Gudewicz, and N. Gilboa Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils Biochem Biophys Res Commun 147 1987 1176 1181
17. B. Gupta, N. Singh, K.K. Saxena, and V.K. Srivastava Topical amiloride solution accelerates healing of mechanical skin ulcers in albino rats Meth Find Exp Clin Pharmacol 22 2000 671 677
18. T. Hasegawa, F. Kaneko, and Y. Niwa Changes in lipid levels and activity of reactive oxygen scavenging enzymes in skin, serum and liver following UVB irradiation in mice Life Sci 50 1992 1893 1903
19. K. Hayashi, M. Berman, D. Smith, A. el-Ghatit, S. Pease, and K.R. Kenyon Pathogenesis of corneal epithelial defects role of plasminogen activator Curr Eye Res 10 1991 381 398
20. A. Ichinose, K. Fujikawa, and T. Suyama The activation of prourokinase by plasma kallikrein and its activation by thrombin J Biol Chem 261 1986 3486 3489
21. J. Jankun, and E. Skrzypczak-Jankun Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride Cancer Biochem Biophys 17 1999 109 123
22. T. Jin, A. Tarkowski, P. Carmelit, and M. Bokarewa Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis Arthritis Res Ther 5 2003 R9 R17
23. C.N. Kennet, S.W. Cox, and B.M. Eley Comparative histochemical, biochemical and immunocytochemical studies on Cathepsin B in human gingiva J Periodont Res 29 1994 201 213
24. H. Kobayashi, M. Schmitt, L. Goretzki, N. Chucholowski, J. Calvete, M. Kramer, W.A. Günzler, F. Jänicke, and H. Graeff Cathepsin B efficiently activates the soluble and tumor receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro u-PA) J Biol Chem 266 1991 5147 5152
25. Z. Lojda The use of substrates with 7-amino-4-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ Acta Histochem 98 1996 215 228
26. Z. Lojda, and J. Čejková Biochemical and histochemical studies of plasminogen activator of urokinase type. I. A simple rapid semiquantitative method for its detection in the tear fluid Acta Histochem 95 1993 232 237
27. Z. Lojda, R. Gossrau, and P.J. Stoward Histochemical methods for proteases 4th ed P.J. Stoward A.G.E. Pearse Histochemistry, theoretical and applied, vol. 3 1991 Churchill Livingstone Edinburgh, New York 639 952
28. J. Martel-Pelletier, M.P. Faure, R. McCollum, F. Mineau, J.M. Cloutier, and J.P. Pelletier Plasmin, plasminogen activators and inhibitors in human osteoarthritic cartilage J Rheumatol 18 1991 1863 1871
29. F. McArdle, L.E. Rhodes, R. Parslew, C.I.A. Jack, P.S. Friedman, and M.J. Jackson UV-induced oxidative stress in human skin in vivo effects of oral vitamin C supplementation Free Rad Biol Med 33 2002 1355 1362
30. K. Morimoto, H. Mishima, T. Nishida, and T. Otori Role of plasminogen activator (u-PA) in corneal epithelial migration Thromb Haemost 69 1993 387 391
31. R.L. O'Grady, L.I. Upfold, and R.W. Stephens Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator Int J Cancer 92 1981 509 515
32. C.W. Oh, J. Hoover-Plow, and E.F. Plow The role of plasminogen in angiogenesis in vivo J Thromb Haemost 1 2003 1683 1687
33. A.K. Sood, B. Gupta, and P. Chugh Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits Methods Find Exp Clin Pharmacol 2 1999 491 497
34. R.W. Stephens, J. Pöllänen, H. Tapiovaara, K.C. Leung, P.S. Sim, E.M. Salonen, E. Ronne, N. Behrendt, K. Dano, and A. Vaheri Activation of pro-urokinase and plasminogen on human sarcoma cells a proteolytic systems with surface-bound reactants J Cell Biol 108 1989 1987 1995
35. J. Tozser, A. Berta, and M. Punyiczk Plasminogen activator activity and plasminogen - independent amidolytic activity in tear fluid from healthy persons and from patients with anterior segment inflammation Clin Chim Acta 183 1989 323 331
36. B.J. Tripathi, J.D. Geanon, and R.C. Tripathi Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study Ophthalmology 94 1987 1434 1438
37. R.C. Tripathi, B.J. Tripathi, and J.K. Park Localization of urokinase-plasminogen activator in human eyes an immunocytochemical study Exp Eye Res 51 1990 545 552
38. A. Vaheri, J. Bizik, E.M. Salonen, H. Tapiovaara, V. Siren, H. Myöhänen, and R.W. Stephens Regulation of the pericellular activation of plasminogen and its role in tissue destructive processes Acta Ophthalmol Suppl. 202 1992 32 41
39. C.J. Van Noorden Direct comparison of enzyme histochemical and immunohistochemical methods to localize an enzyme Mar Environ Res 54 2002 575 577
40. J.D. Vassali, and D. Belin Amiloride selectively inhibits the urokinase-type plasminogen activator FEBS Lett 214 1987 187 191
41. M. Watabe, W. Yano, S. Kondo, Y. Hattori, N. Yamada, R. Yanai, and T. Nishida Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding Invest Ophthalmol Vis Sci 44 2003 3332 3338